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Background: Major depressive disorder is prevalent in the adolescent psychiatric clinical setting and often
comorbid with other primary psychiatric diagnoses such as ADHD or social anxiety disorder. Systematic
manual-based diagnostic procedures are recommended to identify such comorbidity but they are time-consuming
and often not fully implemented in clinical practice. Screening for depressive symptoms in the child psychiatric
context using brief, user-friendly and easily managed self-assessment scales may be of clinical value and utility. The
aim of the study is to test the psychometric validity of two such scales, which may be used in a two-step screening
procedure, the WHO-Five Well-being Index (WHO-5) and the six-item version of Beck’s Depression Inventory (BDI-6).
Method: 66 adolescent psychiatric patients with a clinical diagnosis of major depressive disorder (MDD), 60 girls
and 6 boys, aged 14–18 years, mean age 16.8 years, completed the WHO-5 scale as well as the BDI-6. Statistical
validity was tested by Mokken and Rasch analyses.
Results: The correlation between WHO-5 and BDI-6 was −0.49 (p=0.0001). Mokken analyses showed a coefficient of
homogeneity for the WHO-5 of 0.52 and for the BDI-6 of 0.46. Rasch analysis also accepted unidimensionality when
testing males versus females (p > 0.05).
Conclusions: The WHO-5 is psychometrically valid in an adolescent psychiatric context including both genders to
assess the wellness dimension and applicable as a first step in screening for MDD. The BDI-6 may be recommended
as a second step in the screening procedure, since it is statistically valid and has the ability to unidimensionally
capture the severity of depressed mood.
Keywords: Well-being, Adolescent major depressive disorder, Rasch analyses, Mokken analyses, Brief self-assessment
scales, BDI-6, WHO-5Introduction
Major depressive disorder (MDD) is the most prevalent
psychiatric disorder in teenagers across cultures [1]. In
teenagers MDD is highly comorbid with other psychiatric
disorders such as generalised anxiety disorder, social anx-
iety disorder and ADHD and may have a negative impact
on the prognosis and treatment outcome of the comorbid* Correspondence: eva.henjeblom@ki.se
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reproduction in any medium, provided the ordisorder if not identified and treated [1]. Systematic
manual-based diagnostic procedures have been shown to
help identify comorbid disorders in child and adolescent
psychiatry [2] but are often time-consuming and not fully
implemented in clinical practice. We suggest that screen-
ing for depressive symptoms using brief, user-friendly self-
assessment scales in the child psychiatric context may be
of additive clinical value and utility. A salutogenic scale
has an obvious advantage in avoiding repetitive questions
concerning negative affect and negative life experiences
that may be discouraging for the patient and is therefore
suggested as a first step when screening for depressivetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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screening instrument for the measurement of subjective
well-being [3], see Appendix 1. Recently, Hall et al. exam-
ined the clinical validity of widely used well-being scales
and identified the five-item WHO-5 scale as having the
highest content validity when compared to scales with
a much larger number of items such as the 22-item Psy-
chological General Well-Being Index, the 36-item Medi-
cal Outcome Short Form (SF-36) or the 100-item World
Health Organisation Quality of Life Scale (WHOQoL) [4].
In the follow-up discussion with mental health experts, Hall
et al. state that it is often difficult to avoid the use of items
reflecting either symptoms of illness or side-effects of medi-
cation such as sleep problems or concentration problems
[4]. As a second step in the screening procedure, when the
WHO-5 shows a score below a certain cut-off, an inventory
specifically measuring the pure depressive symptom sever-
ity should be used. For this purpose we have focused on the
short, six-item version (BDI-6) of the Beck Depression In-
ventory [5], see Appendix 2 in which six core items have
been selected from the original version of Beck’s Depression
Inventory to capture MDD unidimensionally in a brief for-
mat [6], thus avoiding unintentionally screening for symp-
toms which might be side-effects of medication. The aim of
this study is to investigate the psychometric properties of
the brief self-rating scales WHO-5 and BDI-6 in a clinical
context of teenagers with MDD with or without other
comorbid psychiatric diagnosis by item Rasch and Mokken
analyses. A two-step screening approach is based on the
fact that the positively phrased items (WHO-5) measure
when “the wind begins to get taken out of the sails”, in
other words an ultra-short screening before the syndrome
of depression is in operation. The negatively phrased items
(BDI-6) measure the cognitive theory of depression.
Method
Self-assessment scales
The WHO-Five Well-being Index (WHO-5) was derived
from a larger rating scale developed for a WHO project
on quality of life in patients suffering from diabetes [7].
During the first psychometric evaluation 10 of the ori-
ginal 28 items were selected due to the homogeneity they
had shown across the various European countries partici-
pating in this study [7]. Because positive psychological
well-being has to include positively worded items only,
these 10 items were then reduced to five items (WHO-5)
which still covered positive mood, vitality and general
interest. The five items are: (a) being in good spirits, (b)
feeling relaxed (c) having energy (d) waking up fresh and
rested, (e) being interested in things. Each of the five
items is rated on a 6-point Likert scale from 0 (= not
present) to 5 (= constantly present). The theoretical raw
score ranges from 0 to 25. Thus, higher scores mean bet-
ter well-being. The raw score is obtained by adding thefigures in the boxes. A score below 13 indicates poor
well-being and is an indication for testing for depression,
as is the case if the patient has answered 0 to 1 on any of
the five items [3]. In order to monitor possible changes
in well-being, the percentage score is used. The percent-
age value is calculated by multiplying the score by 4 and
thus obtaining a scale from 0 (worst imaginable well-
being) to 100 (best imaginable well-being). Convention-
ally > 50 is interpreted as indicating no depression, 30 –
50 mild depression and < 30 moderate depression. A 10%
difference indicates a significant change [8]. Appendix 1
contains the full version of the items. The six items of
the BDI-6 index were derived from the original version
of Beck’s Depression Inventory BDI-21 in a clinical valid-
ation study [6], using experienced psychiatrists as index
of validity, to capture major depressive disorder (MDD)
in a brief format. In this process, 12 items were shown to
follow the global severity index of the experienced
psychiatrists. However, many of these 12 items had local
dependency. Hence, the BDI items 1 (sadness), 2 (pes-
simism) and 4 (lack of satisfaction) showed a very high
local dependency. Moreover, item 5 (guilt), item 3 (sense
of failure) and item 6 (sense of punishment) also had a
very high local dependency. On the other hand, the
selected items in the BDI-6 have a high clinical corres-
pondence to MDD, without being related to each other.
The BDI-6 has not yet been tested or validated in a child
psychiatric population. The six items are: (1) feelings of
sadness, (5) feelings of guilt, (11) being irritable, (13) hav-
ing decision problems, (15) ability to work and (17) feel-
ing tired. When this study was designed, the BDI-II had
not yet been validated for the Swedish version, while BDI-
A1 was in use. The six BDI-6 items were retroactively
extracted from the full 21-item BDI-A1 version. The BDI-
6, as used in this study, thus contains six items on a 4-
point scale yielding a total score by summation of the indi-
vidual items of 0–18 p (0 p means no depression and 18 p
maximum depression score). The conventional cut-off
scores for BDI-6 are < 6 no depression, 6–7 mild depres-
sion, 7 moderate depression. Appendix 2 contains the full
version of the items.
Data collection procedure
The data collection was part of a larger study which has
been described in detail elsewhere [9]. In this study 63
adolescents, 57 girls and 6 boys, aged 14–18 years (mean
age 16.8 years) who were psychiatric patients with a clin-
ical diagnosis of major depressive disorder completed
the WHO-5 scale as well as the BDI A-1. The clinical
diagnosis of MDD was validated by DAWBA, but since
this study aimed at validating the WHO-5 and BDI-6 as
a screening procedure and was not primarily aimed at
studying a group of depressed teenagers all patients were
included, both the ones in whom DAWBA validated the
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nosis of MDD, which was not validated by DAWBA.
Patients with severe autism or psychotic symptoms were
not included in the study. The subjects had on-going
treatment contact (median duration 11 months) at one
of 13 outpatient psychiatric clinics for children and ado-
lescents situated in the centre of Stockholm, its suburbs
and in smaller towns nearby. The subjects completed
the self- assessment forms at the open psychiatric units.
An endeavour was made to collect all data on one occa-
sion, but in some cases new appointments had to be
made to complete all stages of the procedure. This
involved testing one subject at a time under the supervi-
sion of one or two assistants. A randomly sorted pack of
forms was handed to each subject, who was then free to
choose in which order to complete them.
Psychometric analyses
Both Mokken and Rasch methods are based on item re-
sponse theory, thus assuming: (a) unidimensionality,
meaning that for the items that form a scale there is
assumed to be a dominant single latent trait that deter-
mines how the questions are answered, for WHO-5 per-
ceived wellness and for BDI-6 depressed mood, (b) local
stochastic independence of the items in a scale meaning
that a specific individual’s response to items in a scale is
dependent on the individual’s level of the trait being
measured so that the score of one item is not explained
by the score of another item. Local stochastic independ-
ence (conditional independence) should be distinguished
from the problem of the clinical local independence of
items. Statistically, local independence is concerned with
how different item scores are stochastically related
through independence for any fixed level of depression.
Any specific item response is consequently determined
solely by the location on the dimension [10] and the
score level for the specific patient. However, clinically we
are dealing with local independence as a measure (cor-
relation) of the extent to which the score on one item
can automatically predict the score on another item.
The full BDI-21 contains, for example, many such logic-
ally correlating items, as discussed by Greenberg [11],
and finally (c) monotonicity, referring to the probability
of the score of the item increasing as the level of the la-
tent trait increases [12,13]. Invariant item ordering is
one of the key features and a basic principle underpin-
ning the item response theory models. In these models it
is stipulated that items with lower prevalence have to be
preceded by items with higher prevalence for all patients
under consideration [14]. The Rasch model provides a
method for nonlinear transformation of ordinal raw
scores to interval measures and allows the raw scores
from different items representing different severity to be
summated [15]. Estimated by means of the single-parameter Rasch model, the locations (item parameters)
of the theoretical range of the latent dimension of
depression at which the prevalence of items can be placed
are illustrated in the tables. We used the RUMM 2030
program (Andrich D, Sheridan BE, Luo G. RUMM2030.
version 5.1. Perth, WA: RUMM Laboratory Pty Ltd; 2010)
to estimate the item locations.
Mokken analysis is considered a useful way of investigat-
ing the behaviour of items in scales in relation to varying
levels of the latent trait, and the coefficient of homogen-
eity is considered to indicate unidimensionality if > 0.40.
The Mokken analysis has been frequently applied to psy-
chological self-assessment questionnaires [13]. In accord-
ance with the Mokken model, the listing of the individual
items is determined by the mean item scores. In the Mok-
ken scale analyses we used a program for polytomous
items created by Molenaar et al. [16]. Both the parametric
Rasch item response model and the non-parametric Mok-
ken model are only relevant to use if the scales under
examination (WHO-5 and BDI-6) have acceptable clinical
validity. The psychometric validation by Rasch and Mok-
ken is a validation of the measurement aspect answering
the question whether the total score is a sufficient statistic.
The rationale of using both Rasch and Mokken ana-
lyses rather than one or the other is that the Mokken
model shows the coefficient of homogeneity which is
easy to understand, but with the Rasch model we can
check the influence of external factors, e.g. gender.
Results
Of the 66 patients, 40 obtained a diagnosis of MDD when
validated by DAWBA. Using this diagnosis as index, we
found for WHO-5 with the conventional cut-off score of <
50 a sensitivity of 0.80 and a specificity of 0.29. Using the
conventional cut-off score for BDI-6 of < 7 for moderate
depression, we found a sensitivity of 0.50, but a specificity
of 0.83. An ROC analysis confirmed the strategy of the
two-step screening procedure for depression by WHO-5
and BDI-6 (Figure 1). WHO-5 and BDI-6 were not without
convergence (P = 0.38), corresponding to a Spearman coef-
ficient of −0.49 (P < 0.01). However, in 30.3% of cases,
WHO-5 indicates that a BDI-6 depression is in operation
before the BDI-6 cut-off score is reached (Figure 2). The
total score of the five items in the WHO-5 is a sufficient
statistic with a coefficient of homogeneity of 0.52 (Table 1).
Table 1 shows the means (rankings) for the Mokken ana-
lysis of the WHO-5 scale. The three “psychological” items
(item 1, 2, and 5) have the highest rankings, indicating that
they are present in low to moderate degrees of well-being.
The two “somatic” items (4 and 3) have the lowest rankings
indicating that they are only present when high degree of
well-being is perceived. Table 2 shows the Rasch analysis
for the WHO-5 with the three “psychological” items having
the highest locations (up to minus 1.13) and the two
WHO-5 
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==
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Figure 1 ROC analysis showing the results of WHO-5 and BDI-6 of the total subjects (N=66) with clinical diagnosis of major depressive
disorder.
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lysis also accepted unidimensionality when testing males
versus females (p > 0.05). The coefficient of homogeneity
for the BDI-6 was 0.46. Table 3 shows the means (rankings)
for the Mokken analysis of the BDI-6. The two “somatic
items” (17 and 15) showed the highest rankings, indicating
that they are present in low to moderate degree of
depressed mood and the “psychological items” (13, 1, 5, 11)
showed the lowest, indicating that they are only present in
a more severely depressed state. Table 4 shows the Rasch
analysis with the items of “psychological asthenia” or “ap-
athy” having the highest prevalence (items 17 and 15). The
Rasch analysis also accepted unidimensionality when test-
ing males versus females (p > 0.05). The correlation (Spear-
man) between BDI-6 and WHO-5 was −0.49 (p=0.0001).
Discussion
This study shows that the brief self-assessment scales
WHO-5 and BDI-6 have a satisfactory statistical validity
in a sample of adolescents of both genders with a clinical
diagnosis of major depressive disorder (MDD) with orFigure 2 Showing the percentage of convergence between
WHO-5 and BDI-6.without comorbidity of other psychiatric disorders. The
Mokken analysis of the WHO-5 scale shows a coefficient
of homogeneity of 0.52 indicating unidimensionality of
the latent trait of wellness; the analysis of BDI-6 showed
a coefficient of homogeneity of 0.46, indicating that the
total score is a sufficient measure of the pure dimension
of depressed mood. These findings confirm the statistical
validity of using the WHO-5 as a first step in a screening
procedure for depressed mood among adolescent psychi-
atric patients. The total score WHO-5 and BDI-6 showed
an inverse relationship of -0.49 (p<0.0001) indicating that
the two scales partially overlap, but that the wellness di-
mension captures other aspects of well-being than the
absence of depressed mood. Therefore, BDI-6 is needed
as a brief scale that adequately measures the dimension
of depressed mood as a second step when the WHO-5 is
below a certain cut-off. However, we do not suggest this
procedure as an alternative to a proper manual-based
diagnostic interview, which would capture other comor-
bid psychiatric disorders in addition to MDD, but rather
as a convenient and user-friendly complementary way to
screen specifically for depressed mood in situations
when the diagnostic interview is too time-consuming,
impractical or inappropriate to use. Such situations may
be when the patient fails or refuses to cooperation or
when it is too much an effort for the patient to manage a
diagnostic interview. In such cases it is an advantage to
have brief self-assessment scales with a salutogenic focusTable 1 Mokken analysis of WHO-5 showing the means
and items (rankings)








2.22 (1) 1.84 (2) 1.70 (3) 1.12 (5) 1.52 (4)
Coefficients of
homogeneity*
0.11 0.52 0.40 0.53 0.49
*The corresponding coefficient of homogeneity for the total score of WHO-5
(= 0.52).
Table 4 Rasch analysis of the BDI-6 showing the locations
(ranks)
Item 17 Item 15 Item 13 Item 1 Item 5 Item 11
Tiredness Work Decision problems Sadness Guilt Irritability
- 0.26 (1) - 0.23 (2) 0.03 (3) 0.13 (4) 0.16 (5) 0.17 (6)
Table 2 Rasch analysis of WHO-5 showing the locations
(ranks)
Item 1 Item 2 Item 5 Item 4 Item 3
Good spirits Relaxed Interested in things Fresh and rested Energy
−1-13 (1) - 0.26 (2) - 0.22 (3) 0.31 (4) 1.30 (5)



















1 I have felt 5 4 3 2 1 0
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be used for purposes other than for screening. The WHO-
5 can be used across diagnoses to assess well-being as an
aspect of quality of life, either on specific occasions such as
intake and after treatment or in session-by-session assess-
ment, i.e. treatment monitoring [17]. The WHO-5 scale
has been chosen in this study because it specifically aims
to measure positive well-being, in contrast to other short
scales for the measurement of quality of life focusing on
other aspects of health status including morbidity, self-
care, pain etc. The BDI-6 as a unidimensional measure of
depressive symptoms is valid for assessment of treatment
outcome in MDD. Interestingly, the BDI-6 items of sad-
ness, guilt and irritability were reported more frequently as
the severity of depressive symptoms increased, whereas
tiredness and decreased ability to work had the highest
ranking, indicating that these symptoms are present even
when the depressed mood is mild to moderate. The same
tendency was found from a wellness perspective with the
WHO-5. This indicates that depressive symptoms present
themselves in a certain sequence so that in a mild form the
dominant symptoms are tiredness and subjectively reduced
ability to work and when the severity increases feelings of
sadness, guilt and irritability occur. This data supports the
theory of Hamilton that mental illnesses, especially depres-
sion, manifest themselves, so that the patients are the first
to experience a disturbance of their subjective well-being.
Subsequently, family relationships and later their wider so-
cial adjustment are impaired, often with increasingly nega-
tive impact on their global functioning [18].
The study population was limited to patients with mild
to moderate depression and did not include any hospita-
lised psychiatric patients, which limits the generalisabil-
ity of the results to the full spectrum of adolescent
psychiatric patients. The self-assessment forms were dis-
tributed in a random order to prevent systematic errors,Table 3 Mokken analysis of the BDI-6 showing the means
and items (rankings)




1.54 (1) 1.48 1.21 (3) 1.14 (4) 1.12 (5) 1.00 (6)
Coefficients of
homogeneity*
0.49 0.49 0.48 0.40 0.44 0.47
*The corresponding coefficient of homogeneity for the total score of BDI-6
(=0.46).but there could still be an effect of having to complete
several different questionnaires. The BDI was presented
to the subjects as the full 21-item BDI-1A version and
the items of the BDI-6 were retroactively selected. Con-
sequently, we cannot be certain that the scoring of the
six items would have been identical if the BDI-6 had
been presented instead of the full-items version. A few
subjects occasionally mark some items of the BDI-21 be-
tween the specified numbers of 0–4, so that the scores
had to be interpreted as half numbers (0,5; 1,5; 2,5). We
therefore used a 0–6 Likert scale in the analyses, but in
the Mokken mean scores we went back to a 0–3 Likert
scale by dividing the scores by 2 for comparison with
the conventional BDI studies.
Conclusions
We conclude that the WHO-5 is psychometrically sound
and applicable in an adolescent psychiatric context of
clinically depressed teenagers to assess the dimension of
wellness. The WHO-5 scale has the advantage of a salu-
togenic approach and could be used as an initial screen-
ing instrument for depressed mood in a clinical context.
The BDI-6 may be recommended as a second step in
the screening procedure since it is statistically valid and
adequately captures the severity of MDD.
Appendix
Appendix 1 WHO (Five) Well-being Index (1998 version)
Please indicate for each of the five statements which is clos-
est to how you have been feeling over the last two weeks
(Table 5).cheerful and in
good spirits
2 I have felt calm
and relaxed
5 4 3 2 1 0
3 I have felt
active and
vigorous
5 4 3 2 1 0
4 I woke up
feeling fresh
and rested
5 4 3 2 1 0




5 4 3 2 1 0
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1.
A. I do not feel sad (0 p)
B. I feel sad and depressed (1 p)
C. I feel constantly sad and depressed and feel unable to get
out of it (2 p)
D. I feel so blue and unhappy that I cannot bear it (3 p)
5.
A. I don’t feel particularly guilty (0 p)
B. I feel bad or unworthy a good part of the time (1 p)
C. I feel quite guilty (2 p)
D. I feel constantly as though I am guilty and worthless (3 p)
11.
A. I am no more irritable now than I ever was (0 p)
B. I get annoyed or irritable more easily than I used to (1 p)
C. I feel irritated all the time (2 p)
D. I get irritated about things that did not use to irritate me
at all (3 p)
13.
A. I make decisions about as well as ever (0 p)
B. I try to put off making decisions (1 p)
C. I have great difficulty in making decisions (2 p)
D. I cannot make any decisions at all anymore (3 p)
15.
A. I can work about as well as before (0 p)
B. It takes extra effort to get started at doing something (1 p)
C. I have to push myself very hard to do anything (2 p)
D. I can’t do any work at all (3 p)
17.
A. I don’t get more tired than usual (0 p)
B. I get tired more easily than I used to (1 p)
C. I get tired from doing anything (2 p)
D. I get too tired to do anything (3 p)
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